UNSPSC 51293201: Iproniazid or iproniazide

This classification denotes an antidepressive agent and monoamine oxidase inhibitor with the molecular formula C9H13N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D892HFI3XA, chemically known as 4-pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide but generally known as iproniazid, which bears US NIH Compound Identifier 3748. European Medicines Agency schedules Iproniazid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08283MIG.

UNSPSC 51293201 Iproniazid or iproniazide is a Commodity code that bears no relevance to the recent state and local procurement activity posted under it. The code nominally names a specific pharmaceutical compound (iproniazid, a monoamine oxidase inhibitor), but the three recent opportunities tagged to this code solicit naloxone and drug deactivation systems, therapeutic pharmacy initiative capabilities, and generic multi-source pharmaceuticals and OTC products — none of which include iproniazid or fall within the narrow scope of a single-molecule pharmaceutical. The mismatch suggests a coding error in the source data rather than legitimate activity under this Commodity code.

The code shows no recent state and local procurement activity aligned with its actual scope. Practitioners evaluating iproniazid or iproniazide supply should not rely on the opportunities tagged here; the tagging appears to reflect a broad, unspecific application of pharmaceutical codes rather than intentional procurement of this specific agent. Without evidence of recent solicitations for iproniazid itself, this code presents no current market opportunity.